Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
2012;302(1):G19
The phase Ib TROPION-Lung02 trial is a dose-escalation and -expansion study evaluating Dato-DXd (4 or 6 mg/kg) combined with pembrolizumab (doublet) with or without platinum agents (triplet therapy) in both previously untreated and pre-treated patients with metastatic NSCLC without actionable genomic alterations
Return the vial to refrigeration at 2C8C within five minutes of use
Swallowing felt distinctly awkward, and I couldnt get a bite down
US$ 28.25
US$ 27.24
US$ 26.56
US$ 20.07
US$ 29.17
US$ 27.59
US$ 27.25
